Bakkavor Foods USA Inc.

CLOSEOUT LETTER Bakkavor Foods USA Inc. MARCS-CMS 630545 — February 15, 2024 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Food & Beverages Recipient: Recipient Name Mr. Kamran Lodi Recipient Title Chief Operating Officer Bakkavor Foods USA Inc. 2700 Westinghouse Blvd Charlotte , NC 28273 United States Issuing Office: Office of Human and Animal Food Operations – East Division 3 United States Secondary Issuing Offices United States Dear Mr. Lodi: The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter, CMS# 630545 dated August 8, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Victoria L. Palmer Compliance Officer Office of Human and Animal Foods, East Division Office of Regulatory Affairs U.S. Food and Drug Administration Content current as of: 02/20/2024 Regulated Product(s) Food & Beverages